What Is ESBL, and Why Does It Matter for People With Indwelling Catheters?
Written and approved by Dr. Jasmine Bonder and Dr. Adam Bonder
Introduction: A Growing Concern That's Worth Understanding
If you or someone you care for uses an indwelling catheter and has experienced infections that don't respond to the usual antibiotics, you may have heard the term ESBL come up. It's a term that sounds intimidating and represents a genuine clinical challenge, but understanding what it actually means makes it far less mysterious.
ESBL stands for Extended-Spectrum Beta-Lactamase, and it refers to a type of enzyme that certain bacteria produce to defend themselves against many common antibiotics. Bacteria that produce ESBL are considered multi-drug resistant, which means the antibiotics that would normally treat them often don't work. For catheter users, ESBL-producing bacteria are increasingly common, and dealing with them requires a different approach than standard UTI care.
This guide will walk you through what ESBL actually is, why it matters especially for people with indwelling catheters, how it's diagnosed and treated, and what prevention strategies can help. Our goal is to give you clear, honest information about a topic that increasingly affects people managing chronic urinary care.
If you'd like a printable companion resource to bring to your next appointment, you can grab our free Clinova UTI and bladder health guide here anytime.
What Is ESBL?
Extended-Spectrum Beta-Lactamase (ESBL) is an enzyme produced by certain bacteria. The enzyme's job, from the bacterium's perspective, is to break down and neutralize beta-lactam antibiotics before they can damage the bacterial cell.
Beta-lactam antibiotics are a large family of commonly used antibiotics that includes:
Penicillins (amoxicillin, ampicillin, others)
Cephalosporins (cephalexin, ceftriaxone, cefepime, others)
Monobactams (aztreonam)
When bacteria produce ESBL, most of these antibiotics stop working against them. That's why ESBL-producing bacteria are classified as multi-drug resistant. They've essentially developed a chemical shield against a whole category of medications.
Some bacteria also carry additional resistance mechanisms, which means an infection with ESBL-producing bacteria may be resistant to even more antibiotics beyond the beta-lactam family.
Which Bacteria Produce ESBL?
Several bacterial species commonly produce ESBL, most of them from a family called Enterobacteriaceae (bacteria that typically live in the gut).
Most Common ESBL Producers
Escherichia coli (E. coli)* — the same bacterium that causes most recurrent UTIs. ESBL-producing E. coli is the most common resistant urinary tract pathogen worldwide.
Klebsiella pneumoniae — a common cause of catheter-associated UTIs, respiratory infections, and other healthcare-associated infections
Klebsiella oxytoca — related to K. pneumoniae
Proteus mirabilis — often involved in catheter-related infections
Enterobacter species
Citrobacter species
For catheter users, E. coli and Klebsiella are the most commonly encountered ESBL-producing bacteria.
Why ESBL Matters
The clinical importance of ESBL comes down to a few main points.
Limited Treatment Options
When bacteria are resistant to most beta-lactam antibiotics, providers have to reach for stronger, more limited antibiotic options. These often include:
Carbapenems (meropenem, ertapenem, imipenem) — sometimes called "last-line" antibiotics
Aminoglycosides in some situations
Newer combination drugs designed for resistant infections
These medications typically require intravenous (IV) administration, may need hospital care to deliver, and carry more potential side effects than standard oral antibiotics.
Longer, More Complex Treatment
Treating ESBL-producing infections often requires:
Longer courses of antibiotics
More monitoring during treatment
Sometimes hospitalization
More expensive care
More coordination between specialists
Increased Risk of Serious Infection
Untreated or under-treated ESBL infections can:
Progress to more serious systemic illness (sepsis)
Cause kidney infection
Lead to hospitalization
In severe cases, be life-threatening
Contribution to Antibiotic Resistance
Every ESBL infection is part of the broader global antibiotic resistance crisis. Understanding and managing ESBL carefully matters for both individual patients and for public health.
Why Catheters and ESBL Are Particularly Problematic
Indwelling catheters and ESBL-producing bacteria are unfortunately well-matched to cause problems together.
Catheters Provide a Pathway
An indwelling catheter creates a direct route from outside the body into the bladder. Any bacteria in the area, including ESBL producers, can travel this path. This is the same reason catheters increase recurrent UTI risk in general, but with ESBL bacteria the consequences are more serious.
Biofilms Harbor Resistant Bacteria
Bacteria form biofilms on catheter surfaces within days. Biofilms are protective communities that:
Shield bacteria from antibiotics
Allow bacteria to communicate and share resistance genes
Persist over time
Are essentially impossible to eliminate without removing the catheter
Once a catheter is colonized with ESBL-producing bacteria, the biofilm becomes a reservoir that's very difficult to clear.
Antibiotic Exposure Selects for ESBL
Long-term catheter users often have repeated urinary infections, each treated with antibiotics. This repeated antibiotic exposure creates selection pressure that favors resistant bacteria, including ESBL producers. Over time, the personal microbial community shifts toward more resistant organisms.
Hospital and Care Facility Exposure
Catheter users often have contact with healthcare environments where ESBL-producing bacteria are common. This exposure adds to the risk.
Cumulative Effect
The combination of foreign body (catheter), biofilm formation, repeated antibiotic exposure, and healthcare environment contact makes catheter users significantly more likely than the general population to acquire ESBL-producing bacteria.
Who's at Higher Risk
Several factors increase the risk of ESBL colonization or infection:
Long-term or repeated catheter use (both indwelling and intermittent)
Prior antibiotic use, especially cephalosporins and fluoroquinolones
Recurrent UTIs with repeated antibiotic courses
Long-term care facility residence
Hospitalization, particularly ICU stays
International travel, especially to areas with high ESBL prevalence
Immunocompromise (from medications, conditions, or treatments)
Older age
Diabetes
Chronic kidney disease
Living with someone who's colonized with ESBL
For catheter users, many of these risk factors often occur together, which compounds the overall risk.
How ESBL Spreads
Understanding transmission helps with prevention.
Direct Contact
ESBL-producing bacteria can spread through:
Skin-to-skin contact
Hand contact with contaminated surfaces
Shared items in healthcare or care facility settings
Handling of catheter equipment without proper hygiene
Environmental Contamination
The bacteria can survive on surfaces for extended periods, including:
Bed rails
Bathroom fixtures
Medical equipment
Personal items
Shared care spaces
Between People
Family members can share ESBL colonization
Caregivers can transfer bacteria between patients
Healthcare workers with inadequate hand hygiene
Shared living environments
Symptoms: Do ESBL Infections Feel Different?
ESBL-producing bacteria cause the same types of infections as other bacteria. What's different is the treatment challenge, not the initial symptoms.
Standard UTI Symptoms
Symptoms of an ESBL UTI often look like a typical UTI:
Burning with urination
Urgency and frequency
Bladder pain or pressure
Cloudy or foul-smelling urine
Blood in urine
General discomfort
Catheter-Specific Signs
For catheter users, signs of infection may include:
Cloudy, foul-smelling urine in the drainage bag
Sediment or debris in the catheter
Changes in urine color or output
Fever or chills
Increased general discomfort
Confusion or mental status changes (especially in older adults)
Signs of more serious infection
When Infection Progresses
Untreated or under-treated ESBL infections can progress to:
Kidney infection (pyelonephritis) — fever, chills, flank pain, nausea
Bloodstream infection (bacteremia) — significant illness
Sepsis — a life-threatening response requiring emergency care
The key difference with ESBL isn't in how symptoms feel initially but in how the infection responds (or doesn't) to standard antibiotics.
If you or someone you care for has an indwelling catheter and has been dealing with resistant infections, you don't have to navigate this alone. Visit Clinova Solutions to learn how clinician-led telehealth care can help you build a plan that addresses complex urinary situations.
How ESBL Is Diagnosed
Diagnosing an ESBL-producing infection requires more than a standard urine culture.
Urine Culture With Sensitivity Testing
Standard culture identifies the bacteria causing infection
Antibiotic sensitivity testing determines which antibiotics work
ESBL production is often specifically identified
Results typically take 24 to 72 hours
ESBL Confirmation
Labs use specific tests to confirm ESBL production, including:
Disk diffusion tests
Broth microdilution
Automated systems that detect resistance patterns
Molecular tests in some settings
Understanding the Report
When culture results come back showing ESBL production, the report typically indicates:
The bacterial species
Resistant to most cephalosporins
Resistant to certain penicillins
Sensitive to alternative antibiotics (this is what guides treatment)
A knowledgeable provider will use this information to select the right treatment.
Treatment Challenges
Treating ESBL-producing infections requires more thought than standard UTI care.
First-Line Options
For symptomatic ESBL UTIs, treatment often includes:
Carbapenems (meropenem, ertapenem, imipenem) — often the go-to for serious infections
Newer combination drugs developed for resistant infections
Aminoglycosides in specific situations
Fosfomycin (sometimes an option for uncomplicated bladder infections)
Route of Administration
IV antibiotics are often required
Hospital care may be needed for severe infections
Home IV therapy is sometimes an option
Oral options are more limited but expanding
Duration of Treatment
Longer courses than typical UTIs
Often 7-14 days minimum
Sometimes longer for complicated infections
Monitoring throughout treatment
The Reservoir Problem
Even with successful antibiotic treatment, the underlying issue often remains:
The catheter is still present
Biofilms may still harbor bacteria
Colonization can persist
Reinfection is common
This is why treatment often needs to be combined with catheter management strategies.
Prevention Strategies
Prevention is genuinely the best approach with ESBL, both for individual patients and public health.
Minimize Catheter Use When Possible
Remove catheters as soon as medically appropriate
Consider intermittent catheterization instead of indwelling when feasible
Discuss suprapubic catheter options for some long-term users
Regular reassessment of catheter necessity
Judicious Antibiotic Use
Only use antibiotics when actually needed
Complete prescribed courses
Don't use antibiotics for asymptomatic bacteriuria (bacteria in urine without symptoms)
Match antibiotic to organism with sensitivity testing
Excellent Catheter Care
Hand hygiene before every contact with catheter
Closed drainage system kept intact
Proper bag positioning (below bladder, not on floor)
Regular catheter care with mild soap and water
Don't disconnect the system unnecessarily
Consider Bladder Instillation Therapy
For some catheter users with recurrent infections including ESBL:
Bladder instillations can deliver treatment directly to the bladder
GAG layer repair may reduce biofilm formation
Targeted antibiotic instillations may reach bacteria more directly
Anti-inflammatory formulations can support bladder tissue
Hygiene in Care Settings
Hand hygiene for all caregivers
Personal items kept separate
Clean equipment
Report ESBL status to healthcare providers so they can implement appropriate precautions
Infection Prevention
Regular hand washing
Prompt attention to any symptoms
Avoid unnecessary hospital exposure when possible
Follow all infection control guidance from providers
Support Overall Health
Adequate hydration
Good nutrition
Manage underlying conditions (diabetes, immune issues)
Vaginal estrogen for postmenopausal catheter users (with medical guidance)
Want a clear, easy-to-share resource you can bring to your next appointment to discuss ESBL and complex catheter care? Download our free Clinova UTI and bladder health guide.
What Colonization vs. Infection Means
An important distinction that often causes confusion.
Colonization
Having ESBL-producing bacteria present
No symptoms
No inflammatory response
Doesn't require treatment in most cases
Very common in long-term catheter users
Infection
ESBL-producing bacteria are causing symptoms
Inflammatory response present
Requires treatment
May be serious depending on location
Many catheter users are chronically colonized with ESBL-producing bacteria without having an active infection. Treatment isn't always needed for colonization alone. This is where careful clinical judgment matters.
Living With ESBL Colonization
For patients with ongoing catheter use and ESBL colonization:
Not every "positive culture" needs treatment — asymptomatic bacteriuria is common
Monitor for symptomatic infection
Report ESBL status to any new healthcare providers
Practice consistent hygiene
Focus on prevention rather than repeated antibiotic use
Work with providers familiar with complex catheter care
When to Seek Specialized Support
Please reach out to a qualified clinician if you experience:
Symptoms of urinary infection while catheterized
ESBL infections not responding to first-line treatment
Recurrent infections despite standard prevention
Concerns about complex antibiotic resistance patterns
Questions about when to treat vs. monitor colonization
Need for coordination between multiple providers
You should always seek prompt care for:
Fever, chills, or feeling significantly unwell
Severe pain
Confusion or mental status changes
Signs of sepsis
Any concerning changes in someone with a catheter
How Clinova Solutions Can Help
Clinova Solutions specializes in caring for people with recurrent UTIs, chronic urinary symptoms, and the complex urinary situations that come with long-term catheter use. We understand that ESBL and other antibiotic-resistant patterns are increasingly common in this population, and that comprehensive care can make a real difference.
Our approach is built around:
Clinician-led telehealth care so you can access expert support from home
Deep expertise in complex urinary care including catheter management and resistant infections
Personalized plans based on your specific situation, catheter type, and infection history
Bladder instillation therapy for GAG layer support and targeted delivery
Thoughtful antibiotic stewardship that balances treating infections with preventing resistance
Coordination with your other providers for the most comprehensive approach
An education-first philosophy that helps you understand what's happening in your body
You deserve care that takes complex urinary situations seriously and helps you build a plan that supports your overall health.
To take a more informed next step, you can:
Download our free UTI and bladder health guide for a clear, practical resource you can keep and share.
Visit Clinova Solutions to learn more about our care model and how we support people through complex urinary and bladder health situations.
Frequently Asked Questions
What does ESBL stand for?
ESBL stands for Extended-Spectrum Beta-Lactamase. It's an enzyme produced by certain bacteria that breaks down many common antibiotics, making infections harder to treat. Bacteria producing ESBL are considered multi-drug resistant.
Which bacteria produce ESBL?
The most common ESBL-producing bacteria in urinary infections are E. coli and Klebsiella pneumoniae. Other producers include Klebsiella oxytoca, Proteus mirabilis, Enterobacter, and Citrobacter species. Many belong to the Enterobacteriaceae family.
Why are catheter users at higher risk for ESBL?
Catheters create direct pathways for bacteria to enter the urinary tract, accumulate biofilms that harbor resistant bacteria, expose users to repeated antibiotic courses (which select for resistance), and often involve healthcare environment contact. These factors combine to make catheter users significantly more likely to acquire ESBL-producing bacteria.
How is ESBL treated?
ESBL infections often require stronger antibiotics like carbapenems (meropenem, ertapenem, imipenem), which are typically given by IV. Newer combination drugs, aminoglycosides, and fosfomycin may also be options depending on the specific infection. Treatment is often longer and may require hospital care.
Is having ESBL bacteria in my urine the same as having an infection?
No. Having ESBL-producing bacteria in your urine without symptoms is called colonization or asymptomatic bacteriuria. This doesn't usually require treatment. An infection means the bacteria are causing symptoms and inflammation, which does need treatment.
Can I spread ESBL to family members?
It's possible, especially through direct contact and shared living spaces. Good hand hygiene, cleaning shared surfaces, and following any specific guidance from your healthcare team helps reduce spread.
How do I prevent ESBL infections?
Minimize catheter use when possible, use antibiotics only when needed, maintain excellent catheter care and hand hygiene, address contributing factors like hormonal status if appropriate, consider bladder instillation therapy for support, and follow infection control practices in care settings.
What are the "last-line" antibiotics for ESBL?
Carbapenems (meropenem, ertapenem, imipenem) are often used for serious ESBL infections. There are also newer combination drugs specifically designed for resistant infections. These typically require IV administration.
Can bladder instillations help with ESBL infections?
Yes, in some situations. Bladder instillations can deliver antibiotics directly to the bladder (reaching bacteria more effectively than oral antibiotics can) and support the bladder lining. For catheter users with recurrent infections including ESBL, this can be a valuable part of care.
Should I be tested for ESBL colonization?
Routine screening isn't typically done for the general public, but is sometimes done for patients entering certain healthcare settings, being transferred between facilities, or having procedures. If you're a long-term catheter user, your provider may recommend periodic culture testing based on your situation.
What's the difference between ESBL and other resistant bacteria like CRE?
CRE (Carbapenem-Resistant Enterobacteriaceae) is even more resistant than ESBL, being resistant to carbapenems as well. CRE infections are more difficult to treat and often occur in patients who have already been treated for ESBL infections. Both are serious concerns in healthcare-associated infections.
Is ESBL becoming more common?
Yes, unfortunately. ESBL-producing bacteria have become significantly more common globally over the past two decades. Factors include widespread antibiotic use, international travel, healthcare system practices, and evolution of resistance mechanisms. This makes prevention and thoughtful treatment increasingly important.
When should I see a specialist for ESBL concerns?
Anytime you have recurrent infections that aren't responding to standard antibiotics, positive cultures showing resistance patterns, ongoing catheter use with complex infection history, or questions about how to manage ESBL colonization vs. infection. Specialized care makes a meaningful difference in these complex situations.
Follow Along for Ongoing Recurrent UTI Education & Support
Healing starts with understanding what's really going on in your body, and you should not have to figure it out alone.
We regularly share educational content about recurrent UTIs, bladder health, pelvic floor dysfunction, hormones, microbiome balance, prevention strategies, and evidence-informed approaches to chronic urinary symptoms across our social platforms.
Follow us for:
Recurrent UTI education
Prevention tips and symptom support
Bladder health insights
Expert-backed wellness content
New videos resources
Real conversations women are not hearing elsewhere
Facebook: Chronic UTI Care
Instagram: chronicuticare
YouTube: Chronic UTI
We’re here to help women feel informed, supported, and empowered through every stage of their healing journey.
This article is for educational purposes only and is not a substitute for individualized medical advice. Please consult a qualified clinician about your specific symptoms and health history.
Comments